[
    {
        "entity_name": "Anti-TNF therapy",
        "type": "Drug",
        "description": "Therapy using anti-tumor necrosis factor monoclonal antibodies to treat inflammatory bowel disease (IBD).",
        "is_ambiguous": false
    },
    {
        "entity_name": "Inflammatory Bowel Disease (IBD)",
        "type": "Disease",
        "description": "A group of inflammatory conditions of the gastrointestinal tract, primarily including Crohn's disease and ulcerative colitis.",
        "is_ambiguous": false
    },
    {
        "entity_name": "IL-10",
        "type": "Protein",
        "description": "Interleukin 10, a cytokine with anti-inflammatory properties produced by macrophages.",
        "is_ambiguous": false
    },
    {
        "entity_name": "Fc\u03b3 receptor (Fc\u03b3R)",
        "type": "Protein",
        "description": "A receptor that binds to the Fc region of immunoglobulins and is involved in immune response mechanisms.",
        "is_ambiguous": false
    },
    {
        "entity_name": "CD206+ regulatory macrophages",
        "type": "Cell Type",
        "description": "Macrophages that express CD206 and have a regulatory phenotype important for immune regulation.",
        "is_ambiguous": false
    },
    {
        "entity_name": "CD4+CD45Rbhigh T-cells",
        "type": "Cell Type",
        "description": "A subset of T-cells characterized by high expression of CD45Rb, used in models of inflammatory bowel disease.",
        "is_ambiguous": false
    }
]